Okubo Noriyuki, Matsuzaka Masashi, Takahashi Ippei, Sawada Kaori, Sato Satoshi, Akimoto Naoki, Umeda Takashi, Nakaji Shigeyuki
Department of Social Medicine, Hirosaki University Graduate School of Medicine, 5, Zaifu-cho, Hirosaki, Aomori 036-8562, Japan.
BMC Public Health. 2014 Jun 5;14:562. doi: 10.1186/1471-2458-14-562.
To examine an association between self-reported sleep quality determined by Pittsburgh sleep quality index (PSQI) and metabolic syndrome.
This study was designed as cross-sectional study. Participants were 1481 adults aged 20 years and above from general population (549 males and 932 females). We assessed the global sleep quality by PSQI. PSQI consists of 7 elements, i.e. subjective sleep quality, sleep latency (prolonged sleep onset time), sleep duration, habitual sleep efficiency (proportion of hours slept to hours spent in bed), sleep disturbance (interruption of sleep), use of sleep medication and daytime dysfunction (trouble staying awake while engaging in social activity). Any participants with score of 6 or more are diagnosed to have sleep disorder. We also assessed the above 7 elements, which consisted of a four-grade system (i.e. 0, 1, 2, 3). Metabolic syndrome consisted of abdominal obesity, hypertension, impaired glucose tolerance and dyslipidemia. Diagnosis of metabolic syndrome was done when the participants have abdominal obesity and meet two or more other components. All analyses were adjusted by age, drinking habit, smoking habit, working hours, exercise habit and depression.
Fifty-two male participants (9.5%) and 133 female (14.3%) scored 6 or more points in global PSQI score. The global PSQI score, sleep latency score and sleep disturbance score of participants with metabolic syndrome were higher level than those without the condition (p < 0.001, p = 0.009, p = 0.025 for male and p < 0.001, p < 0.001, p = 0.002 for females, respectively). The odds ratio of metabolic syndrome among participants with PSQI score of 6 or more points were 2.37 (95% confidence interval: 1.23-4.58) for males and 2.71 (1.45-5.07) for females in contrast to those with 5 or less points. The odds ratio of metabolic syndrome with sleep latency score of 2 was 2.65 (1.14-6.15) for male and 3.82 (1.81-8.09) for females in contrast with those of 0. The odds ratio of metabolic syndrome with sleep disturbance score of 1 was 1.76 (1.09-2.86) for males and 2.43 (1.26-4.69) for females in contrast with those of 0.
Global PSQI score and its components (especially, sleep latency and sleep disturbance) were associated with metabolic syndrome.
通过匹兹堡睡眠质量指数(PSQI)评估的自我报告睡眠质量与代谢综合征之间的关联。
本研究设计为横断面研究。参与者为1481名20岁及以上的普通人群成年人(549名男性和932名女性)。我们通过PSQI评估整体睡眠质量。PSQI由7个要素组成,即主观睡眠质量、睡眠潜伏期(入睡时间延长)、睡眠时间、习惯性睡眠效率(睡眠时间与卧床时间的比例)、睡眠障碍(睡眠中断)、睡眠药物使用和日间功能障碍(社交活动时难以保持清醒)。任何得分6分及以上的参与者被诊断为患有睡眠障碍。我们还评估了上述7个要素,其采用四级系统(即0、1、2、3)。代谢综合征包括腹型肥胖、高血压、糖耐量受损和血脂异常。当参与者存在腹型肥胖且符合其他两个或更多组成部分时诊断为代谢综合征。所有分析均根据年龄、饮酒习惯、吸烟习惯、工作时间、运动习惯和抑郁情况进行了调整。
52名男性参与者(9.5%)和133名女性(14.3%)在PSQI全球得分中得分为6分及以上。患有代谢综合征的参与者的PSQI全球得分、睡眠潜伏期得分和睡眠障碍得分高于未患该疾病的参与者(男性分别为p < 0.001、p = 0.009、p = 0.025,女性分别为p < 0.001、p < 0.001、p = 0.002)。与PSQI得分5分及以下的参与者相比,PSQI得分6分及以上的参与者中代谢综合征的比值比男性为2.37(95%置信区间:1.23 - 4.58),女性为2.71(1.45 - 5.07)。与睡眠潜伏期得分为0的参与者相比,睡眠潜伏期得分为2的参与者中代谢综合征的比值比男性为2.65(1.14 - 6.15),女性为3.82(1.81 - 8.09)。与睡眠障碍得分为0的参与者相比,睡眠障碍得分为1的参与者中代谢综合征的比值比男性为1.76(1.09 - 2.86),女性为2.43(1.26 - 4.69)。
PSQI全球得分及其组成部分(尤其是睡眠潜伏期和睡眠障碍)与代谢综合征有关。